Molecular mechanisms of suxiao jiuxin pills in ameliorating post-acute myocardial infarction inflammatory response: a combined network pharmacology, Mendelian randomization, and experimental validation study - Summary - MDSpire

Molecular mechanisms of suxiao jiuxin pills in ameliorating post-acute myocardial infarction inflammatory response: a combined network pharmacology, Mendelian randomization, and experimental validation study

  • By

  • Yugen Shi

  • Wenjing Yi

  • Xue Feng

  • Qingshan Zhang

  • Shuai Bao

  • Li Sun

  • Suhua Yan

  • Nannan Li

  • Xiaolu Li

  • July 16, 2026

Share

Objective:

To investigate the target genes associated with Suxiao Jiuxin Pill (SJP) in acute myocardial infarction (AMI) and the underlying biological processes.

Approach:
  • Network Pharmacology and Mendelian Randomization: Utilized network pharmacology and Mendelian randomization analysis to identify target genes and regulatory mechanisms of SJP.
  • Experimental Validation: Established a rat MI model and performed PCR and immunofluorescent labeling to observe gene expression.
Key Findings:
  • Identf4ralyxpsgom689cKwuhv05bJ
Interpretation:

The study provides insights into the molecular mechanisms of SJP in managing AMI.

Limitations:
  • The study primarily relies on data from public databases and may not encompass all relevant biological pathways.
  • Experimental validation was conducted in a rat model, which may not fully replicate human physiology.
Conclusion:

This research enhances the understanding of SJP's mechanisms in treating AMI.

Original Source(s)

Related Content